TY  - JOUR
AU  - Rodríguez-Villodres, Ángel
AU  - Gutiérrez Linares, Alicia
AU  - Gálvez-Benitez, Lydia
AU  - Pachón, Jerónimo
AU  - Lepe, José Antonio
AU  - Smani, Younes
PY  - 2021
DO  - 10.1128/Spectrum.00801-21
UR  - https://hdl.handle.net/10668/27799
T2  - Microbiology spectrum
AB  - Piperacillin/tazobactam (TZP) is a β-lactam/β-lactamase inhibitor (BL/BLI) recommended for the empirical treatment of severe infections. The excessive and indiscriminate use of TZP has promoted the emergence of TZP-resistant Escherichia coli isolates....
LA  - en
KW  - ESRI
KW  - Escherichia coli
KW  - beta-lactamase
KW  - beta-lactamase inhibitor
KW  - piperacillin
KW  - resistance
KW  - tazobactam
KW  - Anti-Bacterial Agents
KW  - Bacteriological Techniques
KW  - Drug Resistance, Multiple, Bacterial
KW  - Escherichia coli
KW  - Escherichia coli Infections
KW  - Humans
KW  - Lactams
KW  - Microbial Sensitivity Tests
KW  - Piperacillin, Tazobactam Drug Combination
KW  - beta-Lactamase Inhibitors
KW  - beta-Lactamases
KW  - beta-Lactams
TI  - Semirapid Detection of Piperacillin/Tazobactam Resistance and Extended-Spectrum Resistance to β-Lactams/β-Lactamase Inhibitors in Clinical Isolates of Escherichia coli.
TY  - research article
VL  - 9
ER  -